HARVARD BIOSCIENCE INC
Harvard Bioscience is a global developer, manufacturer and marketer of life sciences equipment to support research and drug discovery. It is traded on NASDAQ under the stock symbol HBIO. (via Wikipedia)
Market & Alt Data
| Trade Date | Filed | Owner | Role | Type | Shares | Price | Value | Owned After | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-16 | 2026-04-01 | Frost Mark T | Chief Financial Officer | Purchase | 5,000 | $5.00 | $25K | 17.5K | View | |
| 2026-03-17 | 2026-03-18 | DENELSKY STEPHEN J | Director | Purchase | 10.0K | $4.87 | $49K | 21.0K | View | |
| 2026-03-17 | 2026-03-18 | Snider William | Director | Purchase | 8,475 | $4.85 | $41K | 32.0K | View | |
| 2026-03-16 | 2026-03-18 | Snider William | Director | Purchase | 12.5K | $4.99 | $62K | 23.5K | View | |
| 2026-03-16 | 2026-03-17 | Duke John D | Director & Chief Executive Officer | Purchase | 5,000 | $5.01 | $25K | 105.0K | View |
Informational purposes only, not investment advice.
tormere.com/research/HBIO · generated 2026-11-04
Harvard Bioscience is a global developer, manufacturer and marketer of life sciences equipment to support research and drug discovery. It is traded on NASDAQ under the stock symbol HBIO.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-03-16 | Frost Mark T | P | 5,000 | $25,000 |
| 2026-03-17 | DENELSKY STEPHEN J | P | 10,000 | $48,700 |
| 2026-03-17 | Snider William | P | 8,475 | $41,103.75 |
| 2026-03-16 | Snider William | P | 12,525 | $62,499.75 |
| 2026-03-16 | Duke John D | P | 5,000 | $25,050 |
Tormere — informational purposes only, not investment advice.
| Filed | Items | Filing |
|---|---|---|
Aug 11, 2026 accepted 7:00 AM ET | 7.01Reg FD disclosure | DocumentSEC ↗ |
Aug 11, 2026 accepted 7:00 AM ET | 2.02Earnings release | DocumentSEC ↗ |
Jun 2, 2026 accepted 4:01 PM ET | 5.02Officer / director change5.07Shareholder vote | DocumentSEC ↗ |
May 12, 2026 accepted 7:30 AM ET | 7.01Reg FD disclosure | DocumentSEC ↗ |
May 12, 2026 accepted 7:30 AM ET | 2.02Earnings release | DocumentSEC ↗ |
Mar 17, 2026 accepted 7:30 AM ET | 7.01Reg FD disclosure | DocumentSEC ↗ |
Mar 12, 2026 accepted 7:30 AM ET | 2.02Earnings release | DocumentSEC ↗ |
Mar 10, 2026 accepted 7:30 AM ET | 5.02Officer / director change | DocumentSEC ↗ |
Mar 6, 2026 accepted 4:01 PM ET | 5.07Shareholder vote7.01Reg FD disclosure8.01Other events | DocumentSEC ↗ |
Feb 10, 2026 accepted 7:30 AM ET | 2.02Earnings release | DocumentSEC ↗ |